These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15116577)

  • 1. Concentration of clarithromycin and 14-R-hydroxy-clarithromycin in plasma of patients with Mycobacterium avium complex infection, before and after the addition of rifampicin.
    Yamamoto F; Harada S; Mitsuyama T; Harada Y; Kitahara Y; Yoshida M; Nakanishi Y
    Jpn J Antibiot; 2004 Feb; 57(1):124-33. PubMed ID: 15116577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical analysis of drug interaction between rifampicin and clarithromycin which are used for treating pulmonary Mycobacterium avium complex infection].
    Taki H; Ogawa K; Nakagawa T; Kashima K; Tarumi O; Saitou Y; Yamada N; Tano M; Nikai T
    Kekkaku; 2007 Aug; 82(8):641-6. PubMed ID: 17874572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
    Koh WJ; Jeong BH; Jeon K; Lee SY; Shin SJ
    Am J Respir Crit Care Med; 2012 Oct; 186(8):797-802. PubMed ID: 22878282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of rifampicin on the pharmacokinetics of clarithromycin and 14-hydroxy clarithromycin in patients with multidrug combination therapy for pulmonary Mycobacterium avium complex infection.
    Iketani O; Komeya A; Enoki Y; Taguchi K; Uno S; Uwamino Y; Matsumoto K; Kizu J; Hasegawa N
    J Infect Chemother; 2022 Jan; 28(1):61-66. PubMed ID: 34706852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection.
    Wallace RJ; Brown BA; Griffith DE; Girard W; Tanaka K
    J Infect Dis; 1995 Mar; 171(3):747-50. PubMed ID: 7876634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
    Sato K; Ebe T
    Kekkaku; 2000 Jul; 75(7):471-6. PubMed ID: 10944891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perspective of pulmonary MAC infection treatment].
    Kurashima A
    Kekkaku; 2007 Mar; 82(3):195-9. PubMed ID: 17444124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-benefit assessment of therapies for Mycobacterium avium complex infections.
    Griffith DE
    Drug Saf; 1999 Aug; 21(2):137-52. PubMed ID: 10456381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
    Hasegawa N; Nishimura T; Ohtani S; Takeshita K; Fukunaga K; Tasaka S; Urano T; Ishii K; Miyairi M; Ishizaka A
    Chest; 2009 Dec; 136(6):1569-1575. PubMed ID: 19542259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of clarithromycin and active metabolite in the epithelial lining fluid of patients with Mycobacterium avium complex pulmonary disease.
    Hasegawa N; Nishimura T; Watabnabe M; Tasaka S; Nakano Y; Yamazaki K; Hashimoto S; Nishimura M; Ishizaka A
    Pulm Pharmacol Ther; 2009 Jun; 22(3):190-3. PubMed ID: 19061965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimycobacterial synergism of clarithromycin and rifabutin.
    Ghebremichael S; Svenson SB; Källenius G; Hoffner SE
    Scand J Infect Dis; 1996; 28(4):387-90. PubMed ID: 8893404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
    Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period.
    Kobashi Y; Abe M; Mouri K; Obase Y; Kato S; Oka M
    J Infect Chemother; 2012 Aug; 18(4):436-43. PubMed ID: 22205543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
    van Ingen J; Egelund EF; Levin A; Totten SE; Boeree MJ; Mouton JW; Aarnoutse RE; Heifets LB; Peloquin CA; Daley CL
    Am J Respir Crit Care Med; 2012 Sep; 186(6):559-65. PubMed ID: 22744719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical study on efficacy of clarithromycin, levofloxacin, and streptomycin for pulmonary Mycobacterium avium-intracellulare complex infection].
    Taga S; Ogawa K; Nakagawa T; Tano M
    Kekkaku; 2005 Jan; 80(1):1-7. PubMed ID: 15839056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interaction between ritonavir and clarithromycin.
    Ouellet D; Hsu A; Granneman GR; Carlson G; Cavanaugh J; Guenther H; Leonard JM
    Clin Pharmacol Ther; 1998 Oct; 64(4):355-62. PubMed ID: 9797791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
    Tanaka E
    Kekkaku; 1996 Sep; 71(9):547-9. PubMed ID: 8999140
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic efficacy of macrolide in pulmonary nontuberculous mycobacteriosis].
    Tomono K
    Kekkaku; 1994 Nov; 69(11):725-32. PubMed ID: 7837727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.